A presenilin 1 mutation in the first case of Alzheimer's disease: Revisited

@article{Rupp2014AP1,
  title={A presenilin 1 mutation in the first case of Alzheimer's disease: Revisited},
  author={Carsten Rupp and Konrad T. Beyreuther and Konrad Maurer and Stefan Kins},
  journal={Alzheimer's \& Dementia},
  year={2014},
  volume={10},
  pages={869-872}
}

Alzheimer’s Disease: Mechanism and Approach to Cell Therapy

TLDR
The authors discuss the pathogenesis of AD according to the two main neuropathologies, including senescence-related mechanisms and possible treatments using stem cells, namely mesenchymal and neural stem cells.

Alzheimer's disease mouse models based on presenilin-2 N141I: an in vivo study of spontaneous electrical activity by means of hippocampal extracellular recordings

TLDR
The aims of this work were the assessment of the effect of the effects of the PS2-N141I on gamma oscillations in the hippocampus and the identification of novel potential electrophysiological markers for a non-invasive early diagnosis of the pathology.

The Alzheimer's Spectrum: Diagnostic Challenges and Nosology in a Clinically Heterogeneous Disease

  • B. Lam
  • Medicine, Psychology
  • 2017
TLDR
The AD conceptual framework must evolve to acknowledge, define, and anticipate this complexity, harnessing it to improve diagnostic precision and facilitate treatment discovery, and review existing evidence for, provide a specific example of, and investigate the nosological impact of AD heterogeneity.

Molecular and cellular pathophysiology of preclinical Alzheimer’s disease

Alzheimer Mythology: A Time to Think Out of the Box.

  • J. MorleyS. Farr
  • Psychology
    Journal of the American Medical Directors Association
  • 2016

Biomarkers for Alzheimer's disease and the APOE polymorphism

TLDR
Since biomarkers (in particular CSF Aβ42) can reflect pathological changes already in the preclinical stage of the disease, they could become valuable in future AD prevention, once disease-modifying therapies become available.

EFFECTS OF THE NOVEL IDO INHIBITOR DWG-1036 ON THE BEHAVIOUR AND NEUROCHEMISTRY OF THE TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE

This thesis focused on the behavioural and neurochemical effects of a novel IDO inhibitor on the triple transgenic mouse model of Alzheimer's disease.

Alzheimer's Disease Including Focal Presentations

TLDR
Main differential diagnoses include hippocampal sclerosis with TDP‐43, primary age‐related tauopathy, argyrophilic grain disease, frontotemporal lobar degeneration, Lewy body disease, chronic traumatic encephalopathy as well as nondegenerative disorders such as cerebrovascular disease, Chronic alcohol consumption, limbic encephalitis, medial temporal lobe epilepsy, and others.

References

SHOWING 1-10 OF 14 REFERENCES

Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis

TLDR
This case is of historical importance as it may have convinced Kraepelin to name the disease after his co-worker, Alois Alzheimer, and it was shown to be homozygous for apolipoprotein allele ε3 and lacked APP mutations at codons 692, 693, 713 and 717.

Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

TLDR
The histopathology and APOE genotype of Alois Alzheimer's first patient, Auguste D., marks the beginning of research into Alzheimer disease, and neurofibrillary tangles were first described in this brain.

The genetics of Alzheimer disease.

  • R. Tanzi
  • Biology
    Cold Spring Harbor perspectives in medicine
  • 2012
TLDR
The past, present, and future attempts to elucidate the complex and heterogeneous genetic underpinnings of AD are reviewed.

Does the presenilin 2 gene predispose to schizophrenia?

Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases

The Alzheimer disease and frontotemporal dementia (AD&FTLD) and Parkinson disease (PD) Mutation Databases make available curated information of sequence variations in genes causing Mendelian forms of

Genetics, transcriptomics, and proteomics of Alzheimer's disease.

TLDR
An updated overview of the methods used in genetic, transcriptomic, and proteomic studies in Alzheimer's disease is provided and the importance of those methods for the improvement of the current diagnostic and therapeutic possibilities is demonstrated.

Evaluation of DNA extraction methods and real time PCR optimization on formalin-fixed paraffin-embedded tissues.

TLDR
This study indicates that DNA obtained from formalin fixed paraffin embedded tissue is highly fragmented and can be used for successful amplification of shorter amplification products up to 250 bp in length.

Sequencing depth and coverage: key considerations in genomic analyses

TLDR
The issue of sequencing depth in the design of next-generation sequencing experiments is discussed and current guidelines and precedents on the issue of coverage are reviewed for four major study designs, including de novo genome sequencing, genome resequencing, transcriptome sequencing and genomic location analyses.

DNA extraction from archival formalin-fixed, paraffin-embedded tissues: heat-induced retrieval in alkaline solution

TLDR
Results showed that boiling FFPE tissue sections in 0.1 M alkaline solution is a simpler and more effective heat-induced retrieval protocol for DNA extraction, and combination with some chemicals (detergents) may further significantly improve efficiency of the heat- induced retrieval technique.

A presenilin 1 mutation in the first case of Alzheimer's disease